(2020) investigated the interaction between MYC and HDAC2 and reported that HDAC inhibition disrupts the MYC-HDAC2 complex in MYC-amplified medulloblastoma, leading to reduced chromatin binding of MYC. The gene discussed is HDAC2; the disease is medulloblastoma.